HK1066809A1 - Novel immunomodulating compounds - Google Patents

Novel immunomodulating compounds

Info

Publication number
HK1066809A1
HK1066809A1 HK04109875A HK04109875A HK1066809A1 HK 1066809 A1 HK1066809 A1 HK 1066809A1 HK 04109875 A HK04109875 A HK 04109875A HK 04109875 A HK04109875 A HK 04109875A HK 1066809 A1 HK1066809 A1 HK 1066809A1
Authority
HK
Hong Kong
Prior art keywords
compound
relates
present
immunomodulating compounds
novel heterocyclic
Prior art date
Application number
HK04109875A
Other languages
English (en)
Inventor
Per Axel Bjork
Tomas Fex
Lars Olof Goran Pettersson
Poul Sorensen
Dorthe Da Graca Thrige
Original Assignee
Active Biotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Active Biotech Ab filed Critical Active Biotech Ab
Publication of HK1066809A1 publication Critical patent/HK1066809A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04109875A 2001-07-04 2004-12-14 Novel immunomodulating compounds HK1066809A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102404A SE0102404D0 (sv) 2001-07-04 2001-07-04 Novel immunomodulating compounds
PCT/SE2002/001309 WO2003004495A1 (en) 2001-07-04 2002-07-02 Novel immunomodulating compounds

Publications (1)

Publication Number Publication Date
HK1066809A1 true HK1066809A1 (en) 2005-04-01

Family

ID=20284743

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04109875A HK1066809A1 (en) 2001-07-04 2004-12-14 Novel immunomodulating compounds

Country Status (21)

Country Link
EP (1) EP1409485B1 (de)
JP (1) JP2005501033A (de)
CN (1) CN1249063C (de)
AT (1) ATE324373T1 (de)
AU (1) AU2002315996B2 (de)
BR (1) BR0210776A (de)
CA (1) CA2451749A1 (de)
DE (1) DE60210977T2 (de)
ES (1) ES2258150T3 (de)
HK (1) HK1066809A1 (de)
HR (1) HRP20031055B1 (de)
HU (1) HUP0401204A3 (de)
MX (1) MXPA04000017A (de)
NO (1) NO20035684L (de)
NZ (1) NZ530316A (de)
PL (1) PL367637A1 (de)
RU (1) RU2004103079A (de)
SE (1) SE0102404D0 (de)
WO (1) WO2003004495A1 (de)
YU (1) YU101603A (de)
ZA (1) ZA200309806B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ540081A (en) 2002-11-22 2008-03-28 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity
ATE425164T1 (de) 2002-12-16 2009-03-15 Active Biotech Ab Tetrazyklische immunmodulierende verbindungen
GB0305876D0 (en) * 2003-03-14 2003-04-16 Avidex Ltd Immuno inhibitory heterocyclic compounds
KR101133959B1 (ko) * 2003-03-14 2012-04-09 메디진 아게 면역조절 헤테로고리 화합물
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
EP1707567A4 (de) * 2004-01-14 2009-08-19 Ajinomoto Kk Neue verbindung mit kondensiertem ring
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
ATE411318T1 (de) 2004-08-09 2008-10-15 Medigene Ltd Immunmodulierende oxopyrazolocinnoline als cd80- inhibitoren
CN101863903B (zh) * 2010-06-08 2014-03-12 沈阳药科大学 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用
SG11201509411VA (en) * 2013-06-24 2015-12-30 Merck Patent Gmbh Pyrazole compounds as modulators of fshr and uses thereof
EP2883883A1 (de) 2013-12-16 2015-06-17 Cardio3 Biosciences S.A. Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden
US10407316B2 (en) 2014-07-08 2019-09-10 Avertana Limited Extraction of products from titanium-bearing minerals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268516A (en) * 1978-10-11 1981-05-19 Pfizer Inc. [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines
GB8818895D0 (en) * 1988-08-09 1988-09-14 Boots Co Plc Therapeutic agents
ZA895646B (en) * 1988-08-09 1990-04-25 Boots Co Plc Therapeutic agents
SE8903564D0 (sv) * 1989-10-26 1989-10-26 Pharmacia Ab New use condensed quinoline compound
HU9202510D0 (en) * 1990-02-02 1992-10-28 Boots Co Plc Method for producing new 1-benzo-pyrano(4,3)pyrazole derivatives and those of 1-benzo-thiopyrano(4,3)pyrazole and pharmaceutical preparatives containing said compounds
AR006520A1 (es) * 1996-03-20 1999-09-08 Astra Pharma Prod Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.

Also Published As

Publication number Publication date
SE0102404D0 (sv) 2001-07-04
ZA200309806B (en) 2004-12-20
CN1249063C (zh) 2006-04-05
PL367637A1 (en) 2005-03-07
BR0210776A (pt) 2004-07-20
CA2451749A1 (en) 2003-01-16
HUP0401204A2 (hu) 2004-10-28
EP1409485A1 (de) 2004-04-21
RU2004103079A (ru) 2005-06-10
WO2003004495A1 (en) 2003-01-16
EP1409485B1 (de) 2006-04-26
YU101603A (en) 2006-05-25
NO20035684L (no) 2004-03-02
DE60210977T2 (de) 2006-09-21
HRP20031055A2 (en) 2004-06-30
ES2258150T3 (es) 2006-08-16
MXPA04000017A (es) 2004-05-21
DE60210977D1 (de) 2006-06-01
NO20035684D0 (no) 2003-12-19
ATE324373T1 (de) 2006-05-15
JP2005501033A (ja) 2005-01-13
HRP20031055B1 (en) 2008-01-31
CN1522254A (zh) 2004-08-18
AU2002315996B2 (en) 2007-11-29
NZ530316A (en) 2004-08-27
HUP0401204A3 (en) 2008-03-28

Similar Documents

Publication Publication Date Title
HK1086562A1 (en) Pyrazoloquinolines with immunomodulating activity
HK1067120A1 (en) Glutaminyl based dpiv inhibitors
HK1066809A1 (en) Novel immunomodulating compounds
BR0311343A (pt) Derivados de piridazina
WO2002012238A3 (en) 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES
WO2004074244A3 (en) Pyrimidine compounds
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
MXPA05009501A (es) Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
MY129491A (en) Hydrazono-malonitriles
HK1061846A1 (en) New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
WO2003087062A3 (en) 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
WO2005009951A3 (en) Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
WO2004007664A3 (en) Nucleic acid vectors
WO2004087073A3 (en) Treatment of demyelinating conditions
WO2006079720A8 (fr) Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants
HK1061845A1 (en) New process for the industrial synthesis of substituted thiophenecarboxylates, and application of such compounds
ATE425164T1 (de) Tetrazyklische immunmodulierende verbindungen
PL371310A1 (en) Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
WO2004024060A3 (en) Metalloproteinase inhibitors and intermediates for preparation thereof
AU2003227622A1 (en) Methylthiophene carboxanilides
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
WO2007009080A3 (en) Ppar [alpha/gamma] agonists and processes of preparing
ZA200204591B (en) Process for the continuous production of high purity electrolytic zinc or zinc compounds from zinc primary or secondary raw materials.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100702